Results 161 to 170 of about 1,031,391 (295)

Promising Utility of P21-Activated Kinase 4 Expression in the Prediction of Recurrence in Patients with Early-stage Non-small Cell Lung Cancer

open access: yesBiomedical and Biotechnology Research Journal
Background: P21-activated kinase 4 (PAK4), a significant effector of the Rho GTPases, controls various cellular processes and plays a crucial role in cancer progression and metastasis.
Yosra Abdelmonem Zamzam   +3 more
doaj   +1 more source

The Relationship Between Inflammation and Central Nervous System in Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Aim Multiple sclerosis is an autoimmune demyelination disease that is seen especially in the young population and has a progressive course, causing motor, sensory, and cognitive deficits. In the literature, the pathogenesis of MS disease and the interconnection between the immune and central nervous system in the disease have not been fully ...
Gamze Ansen   +5 more
wiley   +1 more source

Thalidomide in Low Intermittent Doses Does Not Prevent Recurrence of Human Immunodeficiency Virus–Associated Aphthous Ulcers [PDF]

open access: bronze, 2001
Jeffrey M. Jacobson   +10 more
openalex   +1 more source

Persistent Leukoencephalopathy Following H1N1 Infection Associated With a Novel MYRF Variant (p.Gly735Asp)

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Mutations in myelin regulatory factor (MYRF) are linked to demyelinating disorders. We report a 38‐year‐old male who developed acute symmetric leukoencephalopathy mimicking a stroke following an influenza A virus infection. While clinical symptoms markedly improved with corticosteroids, MRI revealed persistent white matter lesions, contrasting
Jinghan Hu   +5 more
wiley   +1 more source

Oncological Safety and Recurrence in the Surgical Treatment of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma of the Scalp [PDF]

open access: gold, 2022
Johannes Zeller   +6 more
openalex   +1 more source

Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin   +2 more
wiley   +1 more source

A five‐mRNA signature associated with post‐translational modifications can better predict recurrence and survival in cervical cancer

open access: gold, 2020
Mingyi Ju   +11 more
openalex   +1 more source

Home - About - Disclaimer - Privacy